Plus, news about Disc Medicine, AlloVir, Kalaris, Travere Therapeutics and Trevena: Daiichi Sankyo, Alteogen to develop subcutaneous version of Enhertu: Daiichi will pay $20 million upfront to the ...
A health ministry panel of experts on July 31 endorsed the plan for Daiichi Sankyo Co. to begin producing and distributing the vaccine, which creates immunity for the conventional strain of the virus.
Bạn muốn nhập một dấu gạch ngang dài “—”, được gọi là dấu gạch ngang em (em dash) trên PC Windows hoặc máy Mac của mình, nhưng hoàn toàn không thể tìm thấy nó trên bàn phím, vậy phải làm thế nào ...
Daiichi Sankyo will seek to maintain its edge over competitors in precision cancer therapies by pushing ahead with clinical trials of drug candidates being developed using new technology ...
Hosted on MSN1mon
Daiichi Sankyo: Will Boost ADC Cancer Drug ProductionHiroyuki Okuzawa, President and COO at Daiichi Sankyo, says the company is working to boost production of its newer-generation cancer therapies that target diseased cells, across Japan ...
Prosecutors on Friday called for an 18-year prison sentence for Keisuke Yoshida, a 42-year-old former employee of pharmaceutical giant Daiichi Sankyo, who is on trial for the methanol poisoning ...
(Bloomberg) -- Daiichi Sankyo Co. will seek to maintain its edge over competitors in precision cancer therapies, by pushing ahead with clinical trials of drug candidates being developed using new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback